{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:48:44Z","timestamp":1787755724593,"version":"build-2784847793"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Proximal femoral fractures are often treated with cephalomedullary nails. Although nail breakages following fracture repair are infrequent, a recent implant retrieval study suggested that the TFN-ADVANCED (TFNA) Proximal Femoral Nailing System (DePuy Synthes) was susceptible to post-implant breakage. It is unclear whether the risk of breakage among patients who receive the TFNA implant is higher than patients who receive other comparable cephalomedullary nails. The current study was designed to evaluate the comparative risk of breakage of the TFNA nail.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using data from a large U.S. health-care database, the current study was designed to determine whether TFNA nails have equal, lower, or higher risk of breakage relative to all other comparable, single-head-element (with no additional lag screws), cephalomedullary nails, the Stryker Gamma3 and the Zimmer Natural Nail, referred to in this study as the non-TFNA group. Data were from patients who received the TFNA implant or non-TFNA nails in 365 hospitals between February 1, 2014, and September 30, 2019. Analysis of nail breakage post-implantation was prespecified as the difference between the TFNA group and the non-TFNA group in cumulative incidence at 18 months, with a prespecified equivalence margin of 0.5%, using data balanced on measured covariates by propensity score weighting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Within the first 18 months of implantation, in 14,370 patients with TFNA nails, there were 27 nail breakages, and in 8,260 patients with non-TFNA nails, there were 29 nail breakages. The mean time to nail breakage was 4.72 months for the TFNA group and 4.05 months for the non-TFNA group. In the balanced data, the risk of breakage at 18 months was 0.26% (95% confidence interval [CI], 0.17% to 0.36%) for the TFNA group and 0.25% (95% CI, 0.05% to 0.45%) for the non-TFNA group, with a risk difference of 0.01% (95% CI, \u22120.21% to 0.24%). This result indicates that the cumulative incidence of nail breakage was equivalent (between \u22120.5% and 0.5%) for both nail groups. The risk differences were also within the equivalence margin in subgroup analyses: pertrochanteric fractures only (\u22120.08% [95% CI, \u22120.34% to 0.19%]), pertrochanteric or subtrochanteric fractures (\u22120.04% [95% CI, \u22120.29% to 0.21%]), and those with International Classification of Diseases, Tenth Revision (ICD-10) data only (0.03% [95% CI, \u22120.18% to 0.25%]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The risk of nail breakage was equivalent for TFNA and comparator cephalomedullary nails.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level III<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.20.02002","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T14:16:09Z","timestamp":1621520169000},"page":"1637-1645","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Comparative Safety of the TFN-ADVANCED Proximal Femoral Nailing System"],"prefix":"10.2106","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-6636","authenticated-orcid":false,"given":"Anna","family":"Wallace","sequence":"first","affiliation":[{"name":"Epidemiology & Real-World Data Sciences, Medical Devices, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-9125","authenticated-orcid":false,"given":"James","family":"Amis","sequence":"additional","affiliation":[{"name":"Medical Safety, Medical Devices, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-429X","authenticated-orcid":false,"given":"Guy","family":"Cafri","sequence":"additional","affiliation":[{"name":"Epidemiology & Real-World Data Sciences, Medical Devices, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7078-7780","authenticated-orcid":false,"given":"Paul","family":"Coplan","sequence":"additional","affiliation":[{"name":"Epidemiology & Real-World Data Sciences, Medical Devices, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7757-8124","authenticated-orcid":false,"given":"Jennifer","family":"Wood","sequence":"additional","affiliation":[{"name":"Epidemiology & Real-World Data Sciences, Medical Devices, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"issue":"9","key":"bib1-20250430","doi-asserted-by":"crossref","first-page":"804","DOI":"10.2106\/JBJS.18.00997","article-title":"Implant fracture analysis of the TFNA proximal femoral nail","volume":"101","author":"Lambers","year":"2019","journal-title":"J Bone Joint Surg Am."},{"issue":"23","key":"bib2-20250430","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med."},{"issue":"2","key":"bib4-20250430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00985768","article-title":"Product-limit survival functions with correlated survival times","volume":"1","author":"Williams","year":"1995","journal-title":"Lifetime Data Anal."},{"issue":"16","key":"bib5-20250430","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med."},{"issue":"10-11","key":"bib7-20250430","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1177\/0962280218799540","article-title":"A review and empirical comparison of causal inference methods for clustered observational data with application to the evaluation of the effectiveness of medical devices","volume":"28","author":"Cafri","year":"2019","journal-title":"Stat Methods Med Res."},{"issue":"3","key":"bib8-20250430","doi-asserted-by":"crossref","first-page":"e18174","DOI":"10.1371\/journal.pone.0018174","article-title":"Weight trimming and propensity score weighting","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One."},{"issue":"1","key":"bib9-20250430","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/sim.2739","article-title":"The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials","volume":"26","author":"Rubin","year":"2007","journal-title":"Stat Med."},{"key":"bib10-20250430","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1353\/obs.2018.0009","article-title":"Mitigating reporting bias in observational studies using covariate balancing methods","volume":"4","author":"Cafri","year":"2018","journal-title":"Observational Studies."},{"issue":"6","key":"bib11-20250430","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1080\/10543406.2012.715111","article-title":"Regulatory considerations in the design of comparative observational studies using propensity scores","volume":"22","author":"Yue","year":"2012","journal-title":"J Biopharm Stat."},{"issue":"20","key":"bib12-20250430","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/sim.4002","article-title":"Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority","volume":"29","author":"Goeman","year":"2010","journal-title":"Stat Med."},{"issue":"2","key":"bib14-20250430","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1308\/rcsann.2016.0297","article-title":"Risk factors for intramedullary nail breakage in proximal femoral fractures: a 10-year retrospective review","volume":"99","author":"Johnson","year":"2017","journal-title":"Ann R Coll Surg Engl."},{"issue":"2","key":"bib15-20250430","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00402-014-2121-6","article-title":"Breakage of cephalomedullary nailing in operative treatment of trochanteric and subtrochanteric femoral fractures","volume":"135","author":"von R\u00fcden","year":"2015","journal-title":"Arch Orthop Trauma Surg."},{"issue":"5","key":"bib16-20250430","first-page":"435","article-title":"Implant breakage, a rare complication with the Gamma nail. A review of 843 fractures of the proximal femur treated with a gamma nail","volume":"70","author":"Alvarez","year":"2004","journal-title":"Acta Orthop Belg."},{"issue":"11","key":"bib18-20250430","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2106\/JBJS.17.01222","article-title":"Inability of older adult patients with hip fracture to maintain postoperative weight-bearing restrictions","volume":"100","author":"Kammerlander","year":"2018","journal-title":"J Bone Joint Surg Am."},{"issue":"2","key":"bib20-20250430","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0038-1653746","article-title":"Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials","volume":"73","author":"Rodgers","year":"1995","journal-title":"Thromb Haemost."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.20.02002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:47:19Z","timestamp":1787752039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.20.02002"}},"subtitle":["Findings from a U.S. Health-Care Database"],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":15,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.20.02002","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]}}}